MR formulation food effect [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2012-09-18 21:48 (5030 d 03:29 ago) – Posting: # 9238
Views: 3,861

Hi Dan!

❝ The originator has two MR formulations (A and B; same strength of xxx) on the market. For A the SmPC states no food effect, for formulation B a significant food effect was demonstrated.


Funny. If I could put regulator’s boots on I would politely suggest the innovator to take formulation B off the market.

❝ We aim for formulation A …


Reasonable. ;-)

❝ … and I would like to avoid the single-dose fasted study.


Hhm.

❝ Does Appendix 1 of guideline CPMP/EWP/280/96 Corr * refer to the formulations or to the drug entities itself?


IMHO the former. I would suggest to be a little patient until part II of the new MR draft is published (announced for the end of this month). Maybe we see some enlightening stuff (SD/MD, fasting/fed, etc).


P.S.: For part I see here.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
370 visitors (0 registered, 370 guests [including 21 identified bots]).
Forum time: 01:17 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5